Patents by Inventor Gunter Waxenecker

Gunter Waxenecker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8034338
    Abstract: The invention refers to an immunogenic recombinant antibody designed for immunization of primates comprising at least a part of a murine IgG2a subtype amino acid sequence and a mammalian glycosylation.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: October 11, 2011
    Assignee: Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-AG
    Inventors: Hans Loibner, Gottfried Himmler, Günter Waxenecker, Manfred Schuster, Thomas Putz
  • Publication number: 20110020331
    Abstract: The invention relates to a monoclonal antibody or derivative or fragment thereof that is derived from a parental monoclonal antibody, that recognizes the Lewis Y antigen, characterized in that the Fc region or region equivalent to the Fc region of said antibody or derivative or fragment thereof carries a bi-sected hybrid type N-glycosylation pattern and that said antibody shows at least 10 fold increased ADCC and at least 10% reduced CDC activity.
    Type: Application
    Filed: May 24, 2010
    Publication date: January 27, 2011
    Applicants: MERIDIAN BIOPHARMACEUTICALS GmbH, GREENOVATION BIOTECH GmbH
    Inventors: Manfred Schuster, Gottfried Himmler, Günter Waxenecker, Geert C. Mudde, Manuela Loidl, Gerda Redl, Hans Loibner
  • Publication number: 20100310551
    Abstract: The invention relates to an immunogenic antibody which comprises at least two different epitopes of a tumor-associated antigen.
    Type: Application
    Filed: March 29, 2010
    Publication date: December 9, 2010
    Applicants: MERIDIAN BIOPHARMACEUTICALS GmbH, GREENOVATION BIOTECH GmbH
    Inventors: Hans LOIBNER, Günter WAXENECKER, Gottfried HIMMLER, Helmut ECKERT, Manfred SCHUSTER, Ralf KIRCHEIS
  • Patent number: 7759464
    Abstract: The invention relates to a monoclonal antibody, or fragment of the antibody, that is derived from a parental monoclonal antibody, that recognizes the Lewis Y antigen, characterized in that the Fc region of the antibody, or fragment of the antibody, carries a bi-sected hybrid type N-glycosylation pattern and that the antibody shows at least 10 fold increased ADCC and at least 10% reduced CDC activity.
    Type: Grant
    Filed: July 14, 2004
    Date of Patent: July 20, 2010
    Assignees: Greenovation Biotech GmbH, Meridian Biopharmaceuticals GmbH
    Inventors: Manfred Schuster, Gottfried Himmler, Gunter Waxenecker, Geert C. Mudde, Manuela Loidl, Gerda Redl, Hans Loibner
  • Publication number: 20080095783
    Abstract: The invention relates to a monoclonal antibody or derivative or fragment thereof that is derived from a parental monoclonal antibody, that recognizes the Lewis Y antigen, characterized in that the Fc region or region equivalent to the Fc region of said antibody or derivative or fragment thereof carries a bi-sected hybrid type N-glycosylation pattern and that said antibody shows at least 10 fold increased ADCC and at least 10% reduced CDC activity.
    Type: Application
    Filed: July 14, 2004
    Publication date: April 24, 2008
    Inventors: Manfred Schuster, Gottfried Himmler, Gunter Waxenecker, Geert C. Mudde, Manuela Loidl, Gerda Redl, Hans Loibner
  • Publication number: 20070258978
    Abstract: The invention refers to an immunogenic recombinant antibody designed for immunization of primates comprising at least a part of a murine IgG2a subtype amino acid sequence and a mammalian glycosylation.
    Type: Application
    Filed: April 16, 2004
    Publication date: November 8, 2007
    Inventors: Hans Loibner, Gottfried Himmler, Gunter Waxenecker, Manfred Schuster, Thomas Putz
  • Publication number: 20050181475
    Abstract: The invention relates to an immunogenic antibody which comprises at least two different epitopes of a tumor-associated antigen.
    Type: Application
    Filed: May 15, 2003
    Publication date: August 18, 2005
    Applicant: Igeneon Krebs-Immuntherapie Forschungs-Und-Entwicklungs-AG
    Inventors: Hans Loibner, Gunter Waxenecker, Gottfried Himmler, Helmut Eckert, Manfred Schuster, Ralf Kircheis
  • Publication number: 20040191242
    Abstract: There is disclosed a method of producing an autologous-antibody-containing vaccine, which method is characterized by the following steps:
    Type: Application
    Filed: March 8, 2004
    Publication date: September 30, 2004
    Inventors: Gottried Himmler, Hans Loibner, Helmut Eckert, Otto Doblhoff-Dier, Ralf Kircheis, Manfred Schuster, Erich Wasserbauer, Gunter Waxenecker